Maintenance treatment for opioid dependence with slow‐release oral morphine: a randomized cross‐over, non‐inferiority study versus methadone
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
Aims: To compare the efficacy of slow‐release oral morphine (SROM) and methadone as maintenance medication for opioid dependence in patients previously treated with methadone. Design: Prospective, multiple‐dose, open label, randomized, non‐inferiority, cross‐over study over two 11‐week periods. Methadone treatment was switched to SROM with flexible dosing and vice versa according to period and sequence of treatment. Setting: Fourteen out‐patient addiction treatment centres in S witzerland and G ermany. Participants: Adults with opioid dependence in methadone maintenance programmes (dose ≥50 mg/day) for ≥26 weeks. Measurements: The efficacy end‐point was the proportion of heroin‐positive urine samples per patient and period of treatment. Each week, two urine samples were collected, randomly selected and analysed for 6‐monoacetyl‐morphine and 6‐acetylcodeine. Non‐inferiority was concluded if the two‐sided 95% confidence interval (CI) in the difference of proportions of positive urine samples was below the predefined boundary of 10%. Findings: One hundred and fifty‐seven patients fulfilled criteria to form the per protocol population. The proportion of heroin‐positive urine samples under SROM treatment (0.20) was non‐inferior to the proportion under methadone treatment (0.15) (least‐squares mean difference 0.05; 95% CI = 0.02, 0.08; P > 0.01). The 95% CI fell within the 10% non‐inferiority margin, confirming the non‐inferiority of SROM to methadone. A dose‐dependent effect was shown for SROM (i.e. decreasing proportions of heroin‐positive urine samples with increasing SROM doses). Retention in treatment showed no significant differences between treatments (period 1/period 2: SROM: 88.7%/82.1%, methadone: 91.1%/88.0%; period 1: P = 0.50, period 2: P = 0.19). Overall, safety outcomes were similar between the two groups. Conclusions: Slow‐release oral morphine appears to be at least as effective as methadone in treating people with opioid use disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mersenne twister: a 623-dimensionally equidistributed uniform pseudo-random number generator
Matsumoto, M., & Nishimura, T. (1998) · ACM Transactions on Modeling and Computer Simulation · doi:10.1145/272991.272995 · Cited by 5,780
Dole, V. P. (1965) · JAMA · doi:10.1001/jama.1965.03090080008002 · Cited by 1,240 · cited 1×
“alternative [12].”
Trials to assess equivalence: the importance of rigorous methods: Fig 1
Jones, B., Jarvis, P., Lewis, J. A., & Ebbutt, A. F. (1996) · BMJ · doi:10.1136/bmj.313.7048.36 · Cited by 1,032 · cited 1×
“The statistical analysis was based on a pre-defined non-inferiority margin of 10%, a strict margin for clinical trials in patients with multiple morbidities [34–38].”
MethodAmato, L., Davoli, M., A.Perucci, C., Ferri, M., Faggiano, F., & P. Mattick, R. (2005) · Journal of Substance Abuse Treatment · doi:10.1016/j.jsat.2005.02.007 · Cited by 567 · cited 2×
“methadone, buprenorphine, codeine, diacetylmorphine and morphine, are appropriate for opioid maintenance treatment (OMT) [3], although methadone is the accepted gold standard, with established effectiveness [4].”
BackgroundBuprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
Mattick, R. P., Kimber, J., Breen, C., & Davoli, M. (2008) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002207.pub3 · Cited by 501
Cited by
Strang, J., Volkow, N. D., Degenhardt, L., Hickman, M., Johnson, K., Koob, G. F., Marshall, B. D. L., Tyndall, M., & Walsh, S. L. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0137-5 · Cited by 639
Management of opioid use disorders: a national clinical practice guideline
Bruneau, J., Ahamad, K., Goyer, M.-È., Poulin, G., Selby, P., Fischer, B., Wild, T. C., & Wood, E. (2018) · Canadian Medical Association Journal · doi:10.1503/cmaj.170958 · Cited by 412
Oviedo-Joekes, E., Guh, D., Brissette, S., Marchand, K., MacDonald, S., Lock, K., Harrison, S., Janmohamed, A., Anis, A. H., Krausz, M., et al. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.0109 · Cited by 208
Recommendations for buprenorphine and methadone therapy in opioid use disorder: a European consensus
Dematteis, M., Auriacombe, M., D’Agnone, O., Somaini, L., Szerman, N., Littlewood, R., Alam, F., Alho, H., Benyamina, A., Bobes, J., et al. (2017) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2017.1409722 · Cited by 141
Self-citationTreatment-refractory substance use disorder: focus on alcohol, opioids, and cocaine
Soyka, M., & Mutschler, J. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.11.003 · Cited by 49
Metadata
- Authors
- Beck, T., Haasen, C., Verthein, U., Walcher, S., Schuler, C., Backmund, M., Ruckes, C., & Reimer, J.
- Venue
- Addiction
- Publisher
- Wiley
- Published
- 2014-01-19
- Volume
- 109
- Issue
- 4
- Pages
- 617-626
- ISSN
- 0965-2140 (ISSN-L)
- 1360-0443
- OpenAlex
- W1585445625
- Cited by
- 102
- References
- 5
- FWCI
- 5.67
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.